Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Suspicion of Barrett's esophagus based on either endoscopy or histology only

In September's issue of Gut, the results of a follow up study into endoscopic and histologic procedures used in cases of suspicion of Barrett's esophagus are published.

News image

fiogf49gjkf04

The incidence of distal esophageal adenocarcinoma is rising and chronic reflux and Barrett’s esophagus are both considered risk factors.

At present, reliable detection of Barrett's esophagus dictates the use of upper endoscopy, but both endoscopy and histology are required for accurate confirmation.

Appropriate management of patients with endoscopic suspicion but with negative histology,or of patients with no endoscopic suspicion but with a biopsy diagnosis of intestinal metaplasia at the gastro-esophageal junction, has not yet been studied prospectively.

Researchers from The University of Munich in Germany carried out a prospective multicenter study in which a total of 929 patients (51% male, mean age 50 years) referred for upper gastrointestinal endoscopy were included.

59% of these patients had reflux symptoms.

Researchers noted the endoscopic aspect of the Z line and any suspicion of Barrett’s esophagus. Biopsies were then taken in all patients from the Z line (n = 4), gastric cardia (n = 2), and body and antrum (n = 2 each).

Only 10–20% of cases with either endoscopic or histological suspicion of Barrett’s esophagus had established Barrett's after 2.5 years of follow up
Gut

A reference pathologist reviewed cases in which biopsies were found positive for specialized intestinal metaplasia (SIM) for confirmation of a final Barrett’s esophagus diagnosis.

All patients with endoscopic and/or histological suspicion of Barrett’s esophagus were invited for a follow up endoscopy; the remaining cases (no endoscopic or histological suspicion of Barrett’s esophagus) were followed clinically.

Of the total 235 patients positive for Barrett’s esophagus on endoscopy and/or histology, 63% agreed to undergo repeat endoscopy.

46% of patients with an endoscopic Barrett’s esophagus diagnosis but no histological confirmation showed the same distribution.

A further 42% did not have Barrett’s esophagus, and 11% had confirmed Barrett’s esophagus on both endoscopy and biopsy on follow up.

In the group with a histological Barrett’s esophagus diagnosis who had no findings on initial endoscopy, follow up showed the same in 26% whereas 46% had no Barrett’s esophagus.

Confirmed Barrett’s esophagus (endoscopy plus histology) was diagnosed in 17% of these patients.

Of the study population, 16 patients had Barrett’s esophagus on initial endoscopy confirmed by histology which remained constant in 70% at follow up.

Of the remaining patients without an initial Barrett’s esophagus diagnosis on either endoscopy or histology and only clinical follow up, one confirmed Barrett’s esophagus case was found among 100 patients re-endoscoped outside of the study protocol.

However, no single case of dysplasia or cancer of the distal oesophagus was detected in any patient during the study period.

Professor Rosch commented,"Even in a specialised gastroenterology setting, reproducibility of presumptive endoscopic or histological diagnoses of Barrett’s oesophagus at follow up were poor."

In addition, "Only 10–20% of cases with either endoscopic or histological suspicion of Barrett’s oesophagus had established Barrett’s oesophagus after 2.5 years of follow up."

The group concluded that meticulous follow up may not be required as the risk of dysplasia in this population was shown to be very low.

Gut;2004:53:1402-1407
20 September 2004

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us